Navigation Links
Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)


This press release contains forward looking statements about empagliflozin, an investigational compound being studied for the treatment of type 2 diabetes, and linagliptin, a DPP-4 inhibitor approved for the treatment of type 2 diabetes along with diet and exercise. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date, or that linagliptin will be commercially successful, or that empagliflozin will receive regulatory approvals or prove to be commercially successful or that empagliflozin will receive regulatory approvals or prove to be commercially successful. For further discussion of these and other risks and uncertainties, please see Lilly's latest Forms 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.


Catherine London
Associate Director, Public Relations
Boehringer Ingelheim Pharmaceuticals, Inc.
Phone: (203) 798-4638

Tammy Hull
Communications Manager
Lilly Diabetes
Phone: (317) 651-9116


1.   EASD 2013 online program, Accessed: 
2.   TRADJENTA® (linagliptin) tablets. Highlights of Prescribing Information. June 2013.
3.   International Diabetes Federation. IDF Diabetes Atlas,

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
(Date:3/27/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is celebrating ... Complete Knee System. , ... year since Zimmer first introduced the NexGen knee system, with ... than five million implantations of the NexGen knee have taken ... NexGen knee demonstrates the importance of design innovation and component quality ...
(Date:3/27/2015)... 2015 XRpro Sciences, Inc., a provider ... development services which features high throughput transporter and ... financial results for the year ended December 31, ... of XRpro Sciences commented, "We have completed a ... stage to commercial stage in large part by ...
(Date:3/27/2015)... 27, 2015 Report Details  ... ophthalmic drug companies  What does the future ... industry ? Visiongain,s brand new report shows you potential ... there. Our 242-page report provides 185 tables, ... the industry and the future market prospects. Our new ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... Breast-Specific Gamma Imaging (BSGI) has been proven to be a ... in situ (DCIS), a difficult to diagnose breast cancer. BSGI ... independent of tissue density and discover very early stage cancers. ... the Radiological Society of North America (RSNA), BSGI is an ...
... , , TORONTO, Nov. 30 The Special ... "Company") (TSX: PTI) and JLL Partners, Inc. and its affiliate, ... Company and JLL have entered into a settlement agreement in ... , The settlement provides among other things that: , ...
Cached Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3
(Date:3/27/2015)... On March 19, 2015, at ... Lions wide receiver Herman Moore, hosted “Fighting Addiction ... substance abuse, treatment options and the recent changes ... pastors, ministers and bishops from local churches as ... , “Our ‘Fighting Addiction Together’ luncheon was informative ...
(Date:3/27/2015)... 2015 GenSight, the leading Enterprise Portfolio ... Fitzgerald, a former technology and financial executive to serve ... Chief Financial Officer. , Mr Fitzgerald was most recently ... backed by Amazon founder and CEO Jeff Bezos, Google ... to EverFi, he was a Senior Vice President at ...
(Date:3/27/2015)... WA (PRWEB) March 27, 2015 When ... can be hard to know where to begin. The ... experienced Seattle trucking accident attorney, offers accident victims a ... and legal assistance to ensure their personal injury claim ... begins by describing the first actions that should be ...
(Date:3/27/2015)... St. Paul, MN (PRWEB) March 27, 2015 ... first annual Minnesotans for Healthy Kids Coalition Lobby ... and the Statewide Health Improvement Program (SHIP). ... for the 2015 PE Bill SF343/HF498 which would ... benchmarks, require annual student assessments and other measures ...
(Date:3/27/2015)... Ontario (PRWEB) March 27, 2015 ... in the safe prescribing and utilization of medical ... joined’s network of doctors and clinics dedicated ... ,, a trusted gateway for patients searching ... states and territories, recently launched their sub domain ...
Breaking Medicine News(10 mins):Health Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Canadian Cannabis Clinics (CCC) to Join the Network 2
... made heart implanted inside him last month .This makes ... beat! ,“Heartmate II”, the mechanical heart was implanted inside ... a three-hour surgery on Nov. 23, 2006.This device,is expected to function ... balanced within a magnetic field. Before the surgery, the patient was ...
... difficulty making ends meet and most often end up selling ... study included 1,751 people.// ,People diagnosed with ... report to work regularly and at the same time face ... selling their homes. ,The Macmillan Cancer Support ...
... are not protected from attacks or stroke by taking a ... ,Folic acid or folate is one of the B Vitamins ... medical practitioners prescribe it to prevent cardiac problems. ... Health and Tropical Medicine, New Orleans led a research on ...
... causes cervical cancer as it affects the lining of the ... sexually.// ,Merck & Co. Inc.'s have recently launched ... been proven to prevent cervical cancer. ,The new ... rich countries but it is very doubtful how it would ...
... ,Long shifts done by doctors in the hospitals results// ... rested and well-trained doctors. ,An U.S study by ... working long shifts without rest have an increased risk (300 ... could be prevented. ,The study was based ...
... Deafness Research UK has suggested that certain Christmas toys are ... when 14 toys out of the 15 that// were tested, ... prescribed safety limits of 85 decibels. ,Among ... which included a mechanical toy machine gun, a plastic tommy ...
Cached Medicine News:Health News:Vaccines For Cervical Cancer Will Soon Be Available In Developing Nations 2Health News:Toy Story Turns Bitter-Christmas Toys, No Music to the Ears! 2
... built to be the best stress treadmill ... quieter and more reliable than any competitor, ... safety and comfort of the patient. It ... features include a low profile deck, incredibly ...
... digitally-controlled drive system which eliminates many ... wear out. There are no motor ... fewer drive belts - resulting in ... can carry weights up to 400 ...
... PCE PC-Based Exercise ECG Systems offer clinical ... provide advanced database functionality for paperless storage. ... the Welch Allyn PCE Exercise ECG software ... test system. And with its ability to ...
... systems feature our internationally-acclaimed algorithm that ... algorithm has a proven record for ... situations; and it's just one of ... recognized market leader in the stress ...
Medicine Products: